Answers are grounded in this paper and cite their sources.
Many renowned antibiotics, especially bicyclic β‐lactam‐based representatives, accommodate one or more sulfur atoms in their structure. In this work, the much less explored class of monocyclic β‐lactams was selected as a basis for the construction of unprecedented 3‐amino‐4‐thiomethyl‐β‐lactams, in which a sulfur substituent is connected to the β‐lactam ring via a methylene bridge. To that end, two pathways using different key intermediates, i.e., 4‐hydroxymethyl‐ and 4‐bromomethyl‐β‐lactam systems, were explored. Both approaches enabled the successful preparation of a set of novel thiomethylated azetidin‐2‐ones, featuring different S‐substituents and a well‐defined (relative and/or absolute) configuration. Moreover, further processing demonstrated the possibility to convert these scaffolds into either NH‐β‐lactams or 2‐amino‐4‐thiazolylmethoxyimino‐based derivatives. Thus, these new structures can be considered as eligible platform molecules for further elaboration in the context of antibacterial agent development.
No takes yet. Share an insight, caveat, or question.
Bredael et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: